Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Sudhir Gupta, Roger H. Kobayashi, Jiří Litzman, Laurel Cherwin, Sonja Hoeller & Huub Kreuwel. (2023) Subcutaneous immunoglobulin 16.5% for the treatment of pediatric patients with primary antibody immunodeficiency. Expert Review of Clinical Immunology 19:1, pages 7-17.
Read now
Read now
Omar Benbrahim, Jean-François Viallard, Sylvain Choquet, Bruno Royer, Frédéric Bauduer, Olivier Decaux, Jean-Charles Crave, Yann Fardini, Pierre Clerson & Vincent Lévy. (2019) The use of octagam and gammanorm in immunodeficiency associated with hematological malignancies: a prospective study from 21 French hematology departments. Hematology 24:1, pages 173-182.
Read now
Read now
Grégoire Jacques Noël Cozon, Pierre Clerson, Annaïk Dokhan, Yann Fardini, Taylor Pindi Sala & Jean-Charles Crave. (2018) In-depth interviews of patients with primary immunodeficiency who have experienced pump and rapid push subcutaneous infusions of immunoglobulins reveal new insights on their preference and expectations. Patient Preference and Adherence 12, pages 423-429.
Read now
Read now
Richard F Pollock & Lisa M Meckley. (2018) An evaluation of the budget impact of a new 20% subcutaneous immunoglobulin (Ig20Gly) for the management of primary immunodeficiency diseases in Switzerland. ClinicoEconomics and Outcomes Research 10, pages 223-229.
Read now
Read now
Marlène Pasquet, Isabelle Pellier, Nathalie Aladjidi, Anne Auvrignon, Patrick Cherin, Pierre Clerson, Gregoire Jacques Noël Cozon, Roland Jaussaud, Boris Bienvenu & Cyrille Hoarau. (2017) A cohort of French pediatric patients with primary immunodeficiencies: are patient preferences regarding replacement immunotherapy fulfilled in real-life conditions?. Patient Preference and Adherence 11, pages 1171-1180.
Read now
Read now
E. Hachulla, O. Benveniste, M. Hamidou, L. Mouthon, N. Schleinitz, P. Lozeron, J.M. Léger, C. Vial & K. Viala. (2017) High dose subcutaneous immunoglobulin for idiopathic inflammatory myopathies and dysimmune peripheral chronic neuropathies treatment: observational study of quality of life and tolerance. International Journal of Neuroscience 127:6, pages 516-523.
Read now
Read now
Richard L Wasserman. (2014) Hizentra for the treatment of primary immunodeficiency. Expert Review of Clinical Immunology 10:10, pages 1293-1307.
Read now
Read now
Articles from other publishers (7)
Deepak Menon, Evelyn Sarpong & Vera Bril. (2021) Practical Aspects of Transitioning from Intravenous to Subcutaneous Immunoglobulin Therapy in Neuromuscular Disorders. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 49:2, pages 161-167.
Crossref
Crossref
Francesca Angelotti, Riccardo Capecchi, Daiana Giannini, Ornella Mazzarella, Valeria Rocchi & Paola Migliorini. (2020) Long-term efficacy, safety, and tolerability of recombinant human hyaluronidase-facilitated subcutaneous infusion of immunoglobulin (Ig) (fSCIG; HyQvia(®)) in immunodeficiency diseases: real-life data from a monocentric experience. Clinical and Experimental Medicine 20:3, pages 387-392.
Crossref
Crossref
Deepak Menon, Carolina Barnett & Vera Bril. (2020) Novel Treatments in Myasthenia Gravis. Frontiers in Neurology 11.
Crossref
Crossref
Hulya ANIL, Koray HARMANCİ & Müge AKYÜZ. (2020) Primer İmmün Yetmezlik Tanısıyla Subkutan İmmünglobülin Alan Hastalarımızın Klinik İzlemi. OSMANGAZİ JOURNAL OF MEDICINE 42:6, pages 665-669.
Crossref
Crossref
Elizabeth Schaefer, Santhi Abbaraju, Mary Walsh, Donna Newman, Jacklyn Salmon, Rasidul Amin, Sidney Weiss, Ulrich Grau, Poonam Velagaleti & Brian Gilger. (2016)
Sustained Release of Protein Therapeutics from Subcutaneous Thermosensitive Biocompatible and Biodegradable Pentablock Copolymers (PTS
gels
)
. Journal of Drug Delivery 2016, pages 1-15.
Crossref
Crossref
Luanna Yang, Eveline Y. Wu & Teresa K. Tarrant. (2016) Immune Gamma Globulin Therapeutic Indications in Immune Deficiency and Autoimmunity. Current Allergy and Asthma Reports 16:8.
Crossref
Crossref
Stephen Jolles, Michael Borte, Robert P. NelsonJr.Jr., Mikhail Rojavin, Martin Bexon, John-Philip Lawo & Richard L. Wasserman. (2014) Long-term efficacy, safety, and tolerability of Hizentra® for treatment of primary immunodeficiency disease. Clinical Immunology 150:2, pages 161-169.
Crossref
Crossref